Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations

Date:




The agreements mean the remaining claims against the Swiss maker of generic drugs in the U.S. generic antitrust litigation are those from individual plaintiffs.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

UNM women's basketball looking to bounce back with a pair of home games

ALBUQUERQUE, N.M. (KRQE) - Her first road trip as...

They were NFL losers last year. Now they’re playoff contenders.

Getting to mediocre has taken the entire season. After...

Tencent Profit Flatlines Amid Surging AI Investments, Revenue Growth Slows

The Chinese technology titan’s capital expenditure jumped more than...